Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-26
2005-04-26
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S229500, C544S060000, C544S111000
Reexamination Certificate
active
06884800
ABSTRACT:
Imidazole compounds of the formula Iin whichR1and R2, independently of one another, each denote A1, OA1, SA1or Hal,A1denotes H, A, alkenyl, cycloalkyl or alkylenecycloalkyl,A denotes alkyl having 1-10 carbon atoms,Hal denotes F, Cl, Br or I, andX denotes O, S, SO or SO2,and their physiologically acceptable salts and/or solvates, as phosphodiesterase VII inhibitors, and their use for the preparation of a medicament.
REFERENCES:
patent: 2919271 (1966-12-01), Craig et al.
patent: WO 9015058 (1990-12-01), None
Eggenweiler Hans-Michael
Gassen Michael
Jonas Rochus
Welge Thomas
Wolf Michael
Merck Patent Gesellschaft mit Beschrankter Haftung
Millen White Zelano & Branigan P.C.
Solola Taofiq
LandOfFree
Imidazole compounds used as phosphodiesterase VII inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole compounds used as phosphodiesterase VII inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole compounds used as phosphodiesterase VII inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3366686